Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Primo N Lara

Showing results (61-70 of 274) with videos related to

Pageof 28
Sort By:
Clinical Genitourinary Cancer|January 5, 2023
ATR Inhibition in Advanced Urothelial CarcinomaRyan C Leibrandt, Mei-Juan Tu, Ai-Ming Yu, et al.
Clinical Lung Cancer|August 4, 2019
A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer RegistryDavid J Benjamin, Amy Klapheke, Primo N Lara, et al.
Clinical Genitourinary Cancer|March 3, 2012
Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patientsDerek Shek, Benjamin Tomlinson, Monica Brown, et al.
Clinical Lung Cancer|November 11, 2009
Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012David R Gandara, Philip C Mack, Tianhong Li, et al.
Clinical Lung Cancer|January 15, 2004
Concurrent chemoradiation strategies in the management of unresectable stage III non-small-cell lung cancerPrimo N Lara, Zelanna Goldberg, Angela Davies, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 19, 2015
Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumourNeil Pugashetti, Stanley A Yap, Primo N Lara, et al.
Clinical Lung Cancer|October 10, 2006
Aurora kinase inhibitors: a new class of targeted drugs in cancerOliver Gautschi, Philip C Mack, Angela M Davies, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancerPhilip C Mack, Angela M Davies, Primo N Lara, et al.
Journal of the American Academy of Dermatology|April 17, 2007
Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like diseaseAkhil Wadhera, Emanual Maverakis, Nicholas Mitsiades, et al.
Nature Clinical Practice. Urology|February 9, 2007
Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivationEric C Nelson, Angelo J Cambio, Joy C Yang, et al.
Pageof 28

Showing results (61-70 of 274) with videos related to

Sort By:
Pageof 28
Clinical Genitourinary Cancer|January 5, 2023
ATR Inhibition in Advanced Urothelial CarcinomaRyan C Leibrandt, Mei-Juan Tu, Ai-Ming Yu, et al.
Clinical Lung Cancer|August 4, 2019
A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer RegistryDavid J Benjamin, Amy Klapheke, Primo N Lara, et al.
Clinical Genitourinary Cancer|March 3, 2012
Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patientsDerek Shek, Benjamin Tomlinson, Monica Brown, et al.
Clinical Lung Cancer|November 11, 2009
Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012David R Gandara, Philip C Mack, Tianhong Li, et al.
Clinical Lung Cancer|January 15, 2004
Concurrent chemoradiation strategies in the management of unresectable stage III non-small-cell lung cancerPrimo N Lara, Zelanna Goldberg, Angela Davies, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 19, 2015
Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumourNeil Pugashetti, Stanley A Yap, Primo N Lara, et al.
Clinical Lung Cancer|October 10, 2006
Aurora kinase inhibitors: a new class of targeted drugs in cancerOliver Gautschi, Philip C Mack, Angela M Davies, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancerPhilip C Mack, Angela M Davies, Primo N Lara, et al.
Journal of the American Academy of Dermatology|April 17, 2007
Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like diseaseAkhil Wadhera, Emanual Maverakis, Nicholas Mitsiades, et al.
Nature Clinical Practice. Urology|February 9, 2007
Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivationEric C Nelson, Angelo J Cambio, Joy C Yang, et al.
Pageof 28